Vlado Perkovic shared his thoughts on glomerular disease clinical trial design, a topic on which he presented at #GlomConHawaii. #trialdesign #kidneydisease #glomerulardisease #nephrology #nephtwitter @VladoPerkovic @GlomCon https://t.co/XYFY4uUX6d

@FaiezZANNAD on #composite endpoints. (Think Bouillabaisse 🇫🇷!) #Mosaic2024 #TrialDesign

This approach can be adopted within phase 3 trials. Trialists should address regulatory, payer, institution, clinician, patient requirements within the phase 3 trial design so that the #evidence generated is fit for purpose👇🏽 3/ https://t.co/Mz4JSuZV6R #TrialDesign

What difference does it make to analyse a crossover trial as a parallel-group trial? Data from https://t.co/SMuJWvy2Yj 24 hours of a low-carbohydrate diet on fasting glucose concentrations @AaronHengist #lowcarb #science #trialdesign #stats

Great discussions on #TrialDesign at @franceintheus @AlexMebazaa @hvanspall @thiele_holger @rebeccamathewmd @TomLuscher @ConnorObrienMD @vbluml @JaninePoss @ShashankSinhaMD @SabriSoussi @ACVCPresident #3CT #personalized #medicine #AI #inflammation #biomarker #targeted #therapy

Is anyone aware of any #RCT that demonstrated the efficacy of any intervention in any CVD on the primary #endpoint of “days alive and out of the hospital”? If so, please share. (And what #breakfast are you having to fuel the clinical workday?) #DAOH #TrialDesign

Pleasure to participate in ⁦⁦⁦@sitcancer⁩ #SurrogateEndpoints Summit today & colead #IO Endpoints WG w KOLs from ⁦@theNCI⁩ ⁦@US_FDA⁩ industry academia tackling #trialdesign #biomarkers #immunooncology Report to follow ⁦⁦⁦⁦⁦@MoffittNews⁩

📅 Mark your calendar for #SCOPE24 and meet the #IDDI team of experts! Shruti & Kalyn, our directors of BD USA will be in Orlando 11-14 February and ready to support your upcoming drug development projects! #biostatistics #trialdesign #clinicaldatamanagement #randomization

Thinking about advancing your career in #hepatologyresearch? This fall, join our online program to gain the skills to design, conduct & analyze research in #liverdisease—from foundations & efficient #trialdesign to #statisticalmachinelearning & #knowledgetranslation. Stay tuned!

Regulatory statistics is the backbone of #trialdesign for #drugdevelopment, biomarkers & devices. Our experts will help you determine the right sample size, optimal statistical design, appropriate endpoints and effective #randomization techniques. More: https://t.co/YgZVSbdXAK

Clinical trial #endpoints in pragmatic heart failure #RCTs Insightful review on selection, classification, and data capture of pragmatic trial endpoints led by @vkittipibul #AdamDevore @DCRINews 🔗 https://t.co/uEBM2jQlcR… #TrialDesign #ResearchMethods #RCTs

Join us for the joint @nih_nhlbi @CVCTForum session on #ImplementationScience 8 am, Dec 10 With practical tips & cases that highlight how to design your trial to foster #implementation and how to translate research findings to clinical care. #CVCT24 #CVCT2024 #KT #TrialDesign

Prof Aoife Lowery @GalwayCMNHS talking about innovative #trialdesign in the area of #Cancer as part of the new Institute for #ClinicalTrials @aoifelowery 👏👏 speaking our language 🙏 #futuretrials

New year, new start. Early stage planning and considerations for the type of trial you want to run is critical. Plan early. #trialdesign #evidence #statistics #endpoints #clinicalresearch #clinicaldevelopment

Never not learning, next 4 days very intensively 🤓 @DS_UGent @ugent #postdoclife #clinicaltrials #statistics #trialdesign #WomenInSTEM

I must be at the @franceintheus! An entire afternoon of trial design (and I went easy on the food this time😉😅) With @AlexMebazaa & friends.. #3CT #TrialDesign

Amazing organization today of #AAICNeuro Chicago Hub. In the workshop I introduced #biostatistics & #TrialDesign in non pharmacological trials in dementia & learner about the amazing work being done in this space. The morning sessions are available on demand for 30 days!

#Opthalmologyclinicaltrials require special considerations at each stage. Our panel addresses advances in #trialdesign specific to genetic & #rarediseases of the eye, focusing on #cellandgenetherapy & the need to work collaboratively. Register today. https://t.co/2XyWMgoJE4

As GLP-1 therapies gain traction, trials must evolve to support integrated, patient-centered care. Explore how multidisciplinary models can boost engagement and real-world impact: https://t.co/sI25tH2IPN #PremierResearch #TrialDesign